Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RNN Rexahn Pharmaceuticals, Inc.

5.24

0.00 (0.00%)

Oct 31 2024 - Closed

Delayed by 15 minutes

Rexahn Pharmaceuticals Provides a Clinical Development and Financial Update

Fortified balance sheet to fund initiation of three clinical trials in 2013 with data expected in 2014

Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Rexahn Pharmaceuticals, Inc. Charts.

Rexahn Pharmaceuticals, Inc. (AMEX:RNN)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Rexahn Pharmaceuticals, Inc. Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Rexahn Pharmaceuticals, Inc. News

More Rexahn Pharmaceuticals, Inc. News Articles

Rennova Health (CE)

NioCorp Developments

Anavex Life Sciences

Voip Pal Com (QB)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

Lightwave Logic

Net Savings Link (PK)

Fannie Mae (QB)

Elite Pharmaceuticals (QB)

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions